Hyperlipoproteinemia Type IV

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety Evaluation of Gene Therapy Drug in the Treatment of Primary Hypertriglyceridemic Patients With Recurrent Pancreatitis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hyperlipoproteinemia Type IV, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, hereditary disease, hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, inborn errors of metabolism, metabolic disease	Recruiting	Phase 1	2025-07-03		NCT05860569
Stockholm hyperTRIglyceridemia REGister (STRIREG) Study	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Hyperlipoproteinemia Type IV, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Nutritional and Metabolic Diseases, hereditary disease, hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, inborn errors of metabolism, metabolic disease	Active, not recruiting	Not stated	2023-10-27		NCT06104943

Clinical trials